Northern Trust Company of Connecticut’s Pacira BioSciences PCRX Stock Holding History

Northern Trust Company of Connecticut’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$1.18M	Sell	20,492 -948	-4%	-$49.8K	0.01%	1306
2013 Q3	$1.03M	Buy	21,440 +19,994	+1,383%	+$729K	0.01%	1334
2013 Q2	$42K	Buy	+1,446	New	+$41.8K	﹤0.01%	1897

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Company of Connecticut's PCRX Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Pacira BioSciences (PCRX) stake by 4.4% in Q4 2013, selling an estimated $49.8K and leaving 20,492 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #1306.

Northern Trust Company of Connecticut first reported a position in PCRX in Q2 2013 and has held it in 3 quarters since. 132 funds tracked by Wall St. Rank hold PCRX as of Q4 2013.

Northern Trust Company of Connecticut held 20,492 shares of Pacira BioSciences worth $1.18M as of Q4 2013.
Northern Trust Company of Connecticut sold 948 Pacira BioSciences shares in Q4 2013, an estimated $49.8K.
Pacira BioSciences made up 0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1306 holding.
Northern Trust Company of Connecticut first reported a position in Pacira BioSciences in Q2 2013 and has held it in 3 quarters since.
132 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.